Showing results (271-280 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|April 29, 2021
Excess deaths in treatment-resistant depressionPhilip Brenner, Johan Reutfors, Michel Nijs, et al.Therapeutic Advances in Psychopharmacology|June 18, 2020
Partial compliance with long-acting paliperidone palmitate and impact on hospitalization: a 6-year mirror-image studySofia Pappa, Katy MasonTherapeutic Advances in Psychopharmacology|May 22, 2020
Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case reportJussi Valtonen, Mira KarraschTherapeutic Advances in Psychopharmacology|May 22, 2020
Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorderSadia Anjum, M M A Shalahuddin Qusar, Mohammad Shahriar, et al.Therapeutic Advances in Psychopharmacology|May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkersDmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.Therapeutic Advances in Psychopharmacology|September 9, 2021
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and updateDaniela Adamo, Elena Calabria, Noemi Coppola, et al.Therapeutic Advances in Psychopharmacology|August 16, 2021
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDAMichael P Hengartner, Martin PlöderlTherapeutic Advances in Psychopharmacology|May 24, 2021
Identification of clinical phenotypes in schizophrenia: the role of lurasidoneMarco Andrea Riva, Umberto Albert, Sergio de Filippis, et al.Therapeutic Advances in Psychopharmacology|May 24, 2021
Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC studyPratap Chokka, Holly Ge, Joanna Bougie, et al.Therapeutic Advances in Psychopharmacology|May 26, 2021
Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depressionWei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, et al.Pageof 55